Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion type Assertion NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_head.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion description "[The increasing resistance of falciparum malaria to common antimalarial drugs has renewed interest in the compound proguanil normally metabolized to cycloguanil, a strong dihydrofolate reductase inhibitor, via the cytochrome P450 isozyme CYP2C19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_provenance.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion evidence source_evidence_literature NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_provenance.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion SIO_000772 10471063 NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_provenance.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion wasDerivedFrom befree-20150227 NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_provenance.
- NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_assertion wasGeneratedBy ECO_0000203 NP353545.RApkJsfuwyqbR5a1f_FQ1X7a9FIwl0b2VzIY8lPGHJmFM130_provenance.